The Summary
Researchers developed EMRAge, a biological age biomarker based on routine clinical lab data from 31,000 patients. They then mapped this data to DNA methylation and multi-omics to create DNAmEMRAge and OMICmAge. By combining electronic medical records with epigenetic data, OMICmAge integrates protein, metabolite, and clinical factors while only needing a standard DNA methylation test to run. Validated in over 30,000 additional participants, OMICmAge outperformed existing biomarkers in predicting chronic disease and mortality risk, providing a highly scalable tool for measuring biological age.
Why this is interesting
Previously, biological age clocks relied mostly on standalone DNA methylation patterns, which missed the broader picture of what was actually happening inside your body's proteins and metabolism. This new tool, OMICmAge, bridges that gap by linking those genetic markers directly to real-world medical records and metabolic data. For the general public, this means future biological age tests will be much more accurate and comprehensive without requiring extra blood draws. It offers a clearer window into your true healthspan and disease risk, paving the way for highly personalized preventative medicine.